Injectable hydrogel encapsulating siMMP13 with anti-ROS and anti-apoptotic functions for osteoarthritis treatment.

J Nanobiotechnology · 2024 · PMC11297633 · PMID 39095867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Furthermore, ELISA of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) concentrations in mice serum unveil a decreasing trend in the composite hydrogel group compared to the DMM group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.